Tirzepatide, developed by Eli Lilly and Company, has the ability to lower body weight and regulate blood sugar levels [39]
Patients with certain genetic markers may be predisposed to stronger GI effects, allowing PlexusDx providers to proactively implement prevention strategies and personalize your dose timing or formulation to minimize constipation from the start
Ongoing phase 3 trials may provide further clarity regarding efficacy, safety, and long-term outcomes in liver-specific populations
High expression of a novel carnitine palmitoyltransferase-I like protein in rat brown adipose-tissue and heartisolation and characterization of its Cdna clone
Originally prescribed for diabetes, these drugs now fuel a multibillion-euro weight-loss industry driven by private demand, social media hype, and regulatory gaps
But once again, the results arent definitive